Page last updated: 2024-11-03

ono 1078 and Cognition Disorders

ono 1078 has been researched along with Cognition Disorders in 1 studies

pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist

Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tang, SS1
Ji, MJ1
Chen, L1
Hu, M1
Long, Y1
Li, YQ1
Miao, MX1
Li, JC1
Li, N1
Ji, H1
Chen, XJ1
Hong, H1

Other Studies

1 other study available for ono 1078 and Cognition Disorders

ArticleYear
Protective effect of pranlukast on Aβ₁₋₄₂-induced cognitive deficits associated with downregulation of cysteinyl leukotriene receptor 1.
    The international journal of neuropsychopharmacology, 2014, Volume: 17, Issue:4

    Topics: Amyloid beta-Peptides; Animals; Behavior, Animal; CA1 Region, Hippocampal; Chromones; Cognition Diso

2014